Cuu Long Pharmaceutical JSC

Cuu Long Pharmaceutical JSC EBIT per Share

The EBIT per Share of Cuu Long Pharmaceutical JSC (DCL.VN) as of Oct 29, 2026 is 819.13 VND. In the previous year, EBIT per Share was 968.30 VND — a change of -15.41% (lower).

EBIT per Share

819.13VND

YoY

-15.41%

Last updated:

EBIT per Share of Cuu Long Pharmaceutical JSC is 2024 819.13 VND. EBIT per Share of Cuu Long Pharmaceutical JSC was 2023 968.30 VND. It decreases by -15.41% lower compared to the previous year.

The Cuu Long Pharmaceutical JSC EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2013
2,032.43 VND
Jan 1, 2014
1,658.16 VND
Jan 1, 2015
2,489.40 VND
Jan 1, 2016
1,921.30 VND
Jan 1, 2017
1,646.19 VND
Jan 1, 2018
210.79 VND
Jan 1, 2023
968.30 VND
Jan 1, 2024
819.13 VND
The Cuu Long Pharmaceutical JSC EBIT per Share history
YEAREBIT per ShareYoY
819.13VND-15.41%
968.30VND+359.37%
210.79VND-87.20%
1,646.19VND-14.32%
1,921.30VND-22.82%
2,489.40VND+50.13%
1,658.16VND-18.41%
2,032.43VND-3.79%
2,112.57VND+78.53%
1,183.32VND-10.57%
1,323.24VND-38.71%
2,159.05VND+21.01%
1,784.16VND+22.08%
1,461.49VND+94.02%
753.27VND+22.79%
613.49VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cuu Long Pharmaceutical JSC Stock analysis

What does Cuu Long Pharmaceutical JSC do? Cuu Long Pharmaceutical JSC manufactures and sells pharmaceuticals, capsules, and medical instruments, including functional food, cosmetics, and chemicals for pharmaceutical production. The company imports and exports these products, and also produces specialized packaging for drugs and medical products. It cultivates traditional herbs as part of its operations. The firm targets domestic and international markets for its pharmaceutical and medical product lines, with a focus on manufacturing and distribution. Its products are sold to healthcare providers, pharmacies, and consumers through its own channels and partnerships. Cuu Long Pharmaceutical JSC's revenue streams include the sale of manufactured pharmaceuticals, capsules, medical instruments, functional food, cosmetics, and chemicals. The company also generates income from the export and import of these goods. Specialized packaging for drug and medical product manufacturers is another key revenue source. The cultivation of traditional herbs supports its production of herbal-based pharmaceuticals and supplements. The company serves healthcare providers, pharmacies, and consumers in domestic and international markets. Its product portfolio includes pharmaceutical drugs, capsules, medical equipment, functional food, cosmetics, and herbal products. The firm's manufacturing and distribution capabilities allow it to supply both B2B and B2C segments within the healthcare and wellness industry. Cuu Long Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cuu Long Pharmaceutical JSC stock

EBIT per Share of Cuu Long Pharmaceutical JSC is 819.13 VND in 2024.

EBIT per Share of Cuu Long Pharmaceutical JSC changed from 968.30 VND to 819.13 VND, representing a -15.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Cuu Long Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Cuu Long Pharmaceutical JSC

All Key Metrics — Cuu Long Pharmaceutical JSC